chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Started with Chills approx 8 pm same day as vaccine given.  Developed general weakness/tiredness, fever,  headache,  muscle/joint pain,  nausea, dizziness with made it difficult to walk to the bathroom d/t the dizziness,  general unwell feeling.  I took tylenol.  I applied ice packs to my neck and core body area.   I was confined to the bed until Friday apprx 11:00 am until I could get up.  I continue to feel "funny" in the head at times.  I did not seek any Dr or hospital visit.
Beginning the evening of the event - patient developed fever of 102, chills, fatigue and severe headache. The site of injection is red and swollen. This occurred on Wednesday and symptoms did not resolve until Saturday AM.
I am 53 and had not had a menstrual cycle in 2 years and started my period on Sunday April 25  1 month after 1 st vaccination
Patient said he underarm (armpit and surrounding area) swelled and it felt like it was filling with liquid.  Felt spongy and painfull.
Post vax, the pt's arm began to swell at shoulder and over the next 12 hours it spread to forearm. He also had localized pain at injection site. Some pain in hand joints.
The pt received MMR on 4/27/00. On 5/2/00 the pt woke from a nap with left parotid area swelling, tenderness and induration. No evidence of insect bite, no oral lesions, cavities or gum swelling. No fever.
Vaccine administered beyond Expiration date. However, per Moderna- all vaccines met viability requirements.  Completing VAERS per requirements.
ADACEL vaccine administered when presented with knife laceration to palm of hand requiring 2 stitches.  36 hrs after vaccine arm was swelling, red, & very warm.  C/o generalized achiness, chills & low grade fever.
pt recv vax; extremely fussy & woke up w/ T of 104 R;fever gone but wheezing; to MD;dx of bronchitis;tx w/ Albuterol & Rocephin;Otitis media;bronchitis again 22mar w/ ear infect;
No additional AE details or PQC; Inbound call from HCP stating that an MMR-II was inadvertently administered intramuscularly in and adult instead of subcutaneously. No symptomatic side effects reported. No additional AE details or PQC.; This spontaneous report was received from a licensed practical nurse referring to an adult patient of unknown age and gender. The patient's concomitant medication included sterile diluent (lot # T030955, expiration date: 23-APR-2023, dose was not reported). Medical history, concurrent conditions and drug reaction/allergies were not reported.  On 23-JAN-2023, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (albumin status recombinant Human albumin) (rHA) (M-M-R II) subcutaneous injection (0.5 milliliter [ml], lot # U022174, expiration date: 14-JUL-2023, strength and anatomical site of administration were not provided) inadvertently administered intramuscularly instead of subcutaneously for prophylaxis (incorrect route of product administration). No symptomatic side effects were reported (no adverse event).
pt recvd vax 4OCT95 & 5OCT95 pt devel tinnitus & hearing loss in the lt ear;no further details known as of the date of this report;
the day p/vax pt devel fever of 103;mom gave fever med & brought down;went up the next day to 101;had shiver also;cont to go up in evening to 101 comes down to 99 during the day;
Deep Vein Thrombosis in right calf and right upper leg.  Pfizer booster was on 9-10-2021.  Pain in right calf started 9-13-2021.  Went to emergency room on 9-14-2021 with increasing pain in right calf.
Developed fever 9/26/21, tested 9/28/21 for Covid and received positive result.
Patient was administered expired vaccine (dated April 2014). No adverse reactions were experienced. Manufacturer was contacted immediately and confirmed vaccine was safe and efficacious despite being out of date.
Information has been received from a physician via a field representative referring to a 2 years old male patient. On an unknown date the patient was vaccinated with ROTATEQ (strength, dosage and lot# not reported) orally. On 18-FEB-2015 (reported as "about 2 weeks ago") the patient experienced fever, vomiting, diarrhea and was diagnosed with oral, ROTATEQ. The patient went to seek medical attention and unspecified tests were performed. The outcome of the event was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
Felt like tongue was enlarged and swollen. BP 146/83 (pulse 56). 100% O2 sat. Vitals stable.
Pain on the Right wrist; little Sore Shoulder/Sore Right Shoulder; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (little Sore Shoulder/Sore Right Shoulder) and ARTHRALGIA (Pain on the Right wrist) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced VACCINATION SITE PAIN (little Sore Shoulder/Sore Right Shoulder). On 17-Mar-2021, the patient experienced ARTHRALGIA (Pain on the Right wrist). On 16-Mar-2021, VACCINATION SITE PAIN (little Sore Shoulder/Sore Right Shoulder) had resolved. At the time of the report, ARTHRALGIA (Pain on the Right wrist) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided Treatment information was not provided
Mom states rash started on 5/14/08 on chin.  By the a.m. rash was all over legs and continues to spread.  Patient also running low grade temperature (100.2 rectal) for past 2 days.
Woke up around 3/3:30am (12/8) with migraine and achy all over (teeth, fingers etc), sweating, couldn't find a comfortable position.  Took 1 Motrin PM at 5:30am. Woke at 8am took 1 Sumatriptan 100mg . Took 1 Excedrin Migraine pill at 12pm because of migraine. Took 2 Sumatriptan at 8pm bc of migraine. Fever was holding around 100-101 all day. This morning (12/9) migraine is gone and fever is 99.8. I'm only reporting this because I've never had a reaction to the flu shot before, so this surprised me. (Also, I don't know the lot#, the NDC# is 33332-0420-10
Aches; Sore arm; Fever (101.8°F); This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Aches), PAIN IN EXTREMITY (Sore arm) and PYREXIA (Fever (101.8°F)) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PAIN (Aches), PAIN IN EXTREMITY (Sore arm) and PYREXIA (Fever (101.8°F)). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PAIN (Aches), PAIN IN EXTREMITY (Sore arm) and PYREXIA (Fever (101.8°F)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Mar-2021, Body temperature: 101.8 (High) (101.8°F).         No Concomitant product use was reported. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Follow up received on 05-may-2021 and updated that patient was feeling better now and requested not to follow up again
Information has been received from a licensed practical nurse (L.P.N.) concerning a 14-year-old female, weight 179 pound, height 67.5 inch, who on 10-APR-2008 was vaccinated with a dose of VARIVAX (Merck) subcutaneously that was diluted with MENACTRA. It was reported that the pharmacy sent a MENACTRA in the plastic vial labeled as "sterile solution" instead of the diluent with the VARIVAX (Merck). On the invoice the MENACTRA was listed as the diluent. Lot numbers were not provided. On the eve of vaccination, a local reaction redness at the site was noted. The redness persisted for 2 days. Subsequently, the patient recovered. No product quality complaint was involved. Additional information is not expected.
My entire body has been swollen. I went to the emergency room on Tuesday evening because my throat was starting to swell as well and I was worried I was having an allergic reaction. They said it was not an allergic reaction and gave me steroids. I was on steroids for 4 days. My body continues to be swollen. On  Saturday it started to feel a little harder to breathe, but still possible. On Sunday, most of the lymph nodes in my body became very tender. My lymph nodes are still very tender and my neck and throat are swollen.
Just want to bring to attention my Blood Sugar Readings high by 10-25 points. It started going down again both times after 2 1/2weeks
This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), HEADACHE (Headache), CHILLS (Chills) and NAUSEA (Nausea) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PYREXIA (Fever), HEADACHE (Headache), CHILLS (Chills) and NAUSEA (Nausea). On 10-Mar-2021, HEADACHE (Headache) and CHILLS (Chills) had resolved. At the time of the report, PYREXIA (Fever) and NAUSEA (Nausea) outcome was unknown. Unknown  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.
10 days after receiving vaccine, reported hair loss to PCP. Patient was sent to derm. Mother attempted OTC hair vitamins.
HORRIBLE BACK PAIN (WITH A PAIN SCALE OF 7.5 OUT OF 10); SWOLLEN POUCH ON LEFT LOWER BACK APPROXIMATELY FOUR INCHES DIAMETER AND THREE INCHES HEIGHT DIAGNOSED AS LYMPHATIC ISSUE DUE TO VACCINE; FEVER OF MORE OR LESS 100 F; This spontaneous report received from a consumer concerned a 20 year old male. The patient's weight was 150 pounds, and height was 190 centimeters. The patient's pre-existing medical conditions included the patient had no pertinent medical history. the patient had no known allergies. the patient had no history of drug abuse/ illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, administered on 24-MAY-2021 for prophylactic vaccination. No concomitant medications were reported.  On 24-MAY-2021, the subject experienced horrible back pain (with a pain scale of 7.5 out of 10). On 24-MAY-2021, the subject experienced swollen pouch on left lower back approximately four inches diameter and three inches height diagnosed as lymphatic issue due to vaccine. On 24-MAY-2021, the subject experienced fever of more or less 100 f. Laboratory data included: Body temperature (NR: not provided) more or less 100 F. Treatment medications included: paracetamol. On 25-MAY-2021, Laboratory data included: Blood test (NR: not provided) Unknown. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from swollen pouch on left lower back approximately four inches diameter and three inches height diagnosed as lymphatic issue due to vaccine on MAY-2021, and was recovering from horrible back pain (with a pain scale of 7.5 out of 10), and fever of more or less 100 f. This report was non-serious. This case, from the same reporter is linked to 20210557778.
erythema developed 6 days after administration of vaccine at vaccine administration site. no other signs/symptoms at the time.
Ascending aortic aneurysm/ thoracic ascending aortic aneurysm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 63-year-old male patient received BNT162b2 (BNT162B2), as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunisation; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 immunisation; Bnt162b2 (DOSE 3 (BOOSTER), SINGLE), for COVID-19 immunisation; Bnt162b2 (DOSE 4 (BOOSTER), SINGLE), for COVID-19 immunisation. The following information was reported: AORTIC ANEURYSM (non-serious), outcome "unknown", described as "Ascending aortic aneurysm/ thoracic ascending aortic aneurysm". The event "ascending aortic aneurysm/ thoracic ascending aortic aneurysm" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Patient stated his doctor has been telling him to take it (the Pfizer COVID bivalent booster). He got all the originals, he got 3 vaccines and 2 boosters with the old stuff, but he has a heart condition as well. He has no idea if this condition was present before the vaccines, he had not seen a doctor since he went to a paediatrician. He has an ascending aortic aneurysm and it was not diagnosed prior to the vaccines. He stated they want to avoid, with that condition, as much information as possible. He wanted to know if the bivalent was safe with a thoracic ascending aortic aneurysm and it is dilated 4.3 cm. He found research that said because of the spike proteins you want to avoid it and that was through withheld medical centre. He stated his cardiologist has not gotten back to him about getting it, but his primary provider told him to go get. The caller wanted to know if it is safe to get the bivalent vaccine with a thoracic ascending aortic aneurysm.   The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Student was given 2 immunizations, left vaccination station. As he and mom were standing at check-out table, he suddenly fell to floor. LOC approximately 10-15 sec. - eyes open but not responding verb. Nurse called immed to student, ice pack applied to occipital area - swelling on back of head noted approx half dollar size. Within 30 sec, student trying to sit, oriented to name and age and birth date and to location when asked. C/O post head hurting, VS stable per RN, within 2-3 min, student assisted to mat et juice given. See nurses notes. 5-27-10 Spoke with mom on phone. She states "he's fine." States he was seen last night in ED and "was there about a half an hour." She states they were instructed to "keep an eye on him and keep him awake" and to keep out of school today. Mom also stated "I should have known because he did this before at the eye doctor but he seemed OK." She states student told her afterward that he felt fine, started to get lightheaded but did not tell her before he had syncopal episode. Addendum: I also informed mom I would be submitting VAERS report.
Patient became agitated approximately 15 minutes after giving her the first dose of covid-19 vaccination (Pfizer).  Before giving her the vaccine she did seem nervous about it. While sitting in the waiting area after the vaccine was administered, the patient said that her angina was acting up. She did take 1 nitroglycerin tablet an got some relief.  About 15 minutes later she became agitated again and took another nitroglycerin and again got some relief.  She called a family member and explained what was happening. She did not feel that she needed an ambulance. After about an hour she was able to return to her room. I spoke to her on weekend and she felt better.
I had a large, bright red patch surrounding the area where I had received my flu shot. The red area was also warm to the touch and tender. The area was light pink on the morning of 10/06.
sore left arm/ injection site arm; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (sore left arm/ injection site arm) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (sore left arm/ injection site arm). At the time of the report, VACCINATION SITE PAIN (sore left arm/ injection site arm) outcome was unknown.            No concomitant medications were reported. No treatment details were reported.   This case was linked to MOD-2022-438831 (Patient Link).
Female patient received first dose of Shingrix 22Aug2020, and has not yet received second dose.; This case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a 59-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose (lot number 7BC47, expiration date 29th June 2023) received on 22nd August 2020 prior before reporting.).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 15th June 2022 Reporters comment: The reporter was a Pharmacy Operations Manager. The VAERS details was reported for 1st dose.  The reporter consent for follow-up. Additional Supportive information: Till the time of reporting, the patient did not receive 2nd dose, which led to incomplete course vaccination. This case had been linked with US2022093603, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022093603:Same reporter.
Lack of Response - Information has been received from a physicain concerning a 29 year old female who, years ago, was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live second generation.   She received a second dose in January 2000.  Sebsequently the patient had titers drawn and rubeola came back questionable.
Vaccination site discharge; Vaccination site lump; Sleep difficult; Vaccination site pruritus; Vaccination site erythema; Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCHARGE (Vaccination site discharge), VACCINATION SITE MASS (Vaccination site lump), INSOMNIA (Sleep difficult), VACCINATION SITE PRURITUS (Vaccination site pruritus) and VACCINATION SITE ERYTHEMA (Vaccination site erythema) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE DISCHARGE (Vaccination site discharge), VACCINATION SITE MASS (Vaccination site lump), INSOMNIA (Sleep difficult), VACCINATION SITE PRURITUS (Vaccination site pruritus), VACCINATION SITE ERYTHEMA (Vaccination site erythema) and VACCINATION SITE PAIN (Vaccination site pain). At the time of the report, VACCINATION SITE DISCHARGE (Vaccination site discharge), VACCINATION SITE MASS (Vaccination site lump), INSOMNIA (Sleep difficult), VACCINATION SITE PRURITUS (Vaccination site pruritus), VACCINATION SITE ERYTHEMA (Vaccination site erythema) and VACCINATION SITE PAIN (Vaccination site pain) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment medications were not provided by the reporter.    This case was linked to MOD-2021-376963 (Patient Link).   Reporter did not allow further contact
Case number PHEH2013US000864 is an initial spontaneous report received from a nurse on 07 Jan 2013. This report refers to an adult male patient whose age was not reported. It was reported that he was inadvertently vaccinated with an intramuscular dose of Men A lyophilized conjugate component of MENVEO (batch number: M11042) reconstituted with sterile water instead of being reconstituted with MenCYW-135 liquid component on 26 Dec 2012. No adverse reaction was reported following the medication error.
CORONAVIRUS COVID-19 DISEASE  -  COVID test : positive on 11/16/21.   Pt started on remdesivir and decadron on admission.   However remdesivir had to be discontinued due to Cr.   Down to room air now the past 2 days and feeling well.   Stable for discharge.       AKI  CKD STAGE 3B (GFR 30-44) (9/7/2021)  - suspect AKI due to hypovolemia from covid diarrhea, decreased oral intake on top of losartan.   Given some IVF 11/21/21 and Cr with some improvement.  FeNA consistent with prerenal.   Cr back up a little after restarting remdesivir 11/22/21, prompting discontinuation of remdesivir all together on 11/232/21.  Cr down again today.
Seen at Doctor's office on 10/26/17. Has had daily fevers since 10/19/17 as high as 102. Denies any other symptoms other than chills and fatigue.
This spontaneous report was received from a registered nurse and refers to a 13-year-old patient of unknown gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 21-DEC-2018, the patient was vaccinated with improperly stored dose of GARDASIL 9 lot # 1586752, expiration date 16-FEB-2021 (dose and route of administration were not reported). Administered dose of vaccine experienced the temperature excursion of 31.1 Fahrenheit degrees (F) (below 32 F/ 0 Celsius degrees) (30 cycles) for 35 hours 30 minutes. There were no previous excursions reported. The digital data logger was involved to capture the temperature excursion. No adverse effects were reported. This is one of multiple reports received from the same reporter (it was reported that it was unknown which lot numbers of each specific vaccine were administered to which patient).; Sender's Comments: US-009507513-1901USA000071:
feeling very, very  dizzy/dizziness; diarrhea; This is a spontaneous report received from a contactable consumer. A 80-year-old female consumer (patient) received first dose of bnt162b2 (PFIZER- BIONTECH COVID-19 VACCINE, solution for injection), (Batch/lot number: EL3249) on 20Jan2021 at single dose for COVID-19 immunisation. The medical history of the patient included genito arthritis and asthma. The concomitant medication was not provided. On 20-JAN-2021 patient was feeling very, very dizzy and diarrhea. Patient was concerned about diarrhea as she got a shot 20Jan2021 and on 27Jan2021 she was still experiencing diarrhea. The patient took the vaccine on last Wednesday and had side effects or dizziness and 2 days later I started with diarrhea which is going on now. Patient did not received any treatment. Patient had some blood work done. The outcome of the event was unknown.  Follow-up attempts are completed. No further information is expected.
1/22/21, the day after the I received the vaccine I started to have chills, body aches, low grade fever, headache, nausea, lack of appetite, and arm pain in the right arm. This lasted for two days. On day 3 I began to feel dizzy and have extreme low back pain and stomach pain with nausea with again lack of appetite. By this time the body aches and arm pain went away but I still have a headache. Now on day 4 the low back pain has gone away but still I have a headache and lack of appetite and nausea.
Pt recvd 3 doses of Engerix-B & Hep B surface antibody titer was borderline-subtherapeutic; pt was advised to receive a 4th dose & be retested;